Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Contraceptives Market Size Forecast: How Big Could The Market Get By 2030?
The contraceptives market size has demonstrated significant expansion in recent years. It is projected to expand from $29.74 billion in 2025 to $32.02 billion in 2026, driven by a compound annual growth rate (CAGR) of 7.7%. The observed growth in previous periods can be linked to factors such as government-led family planning programs, improved access to oral contraceptive pills, an increase in urban female workforce participation, public health campaigns aimed at population control, and the expansion of contraceptive services offered by hospitals and clinics.
The contraceptives market is projected to experience substantial growth in the upcoming years. It is anticipated to reach $43.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is fueled by several factors, including advancements in non-hormonal and male contraceptive innovations, the increasing reach of online pharmacies, heightened reproductive health awareness among adolescents, continuous technological progress in implantable devices, and favorable regulatory approvals for new contraceptives. Key trends expected in this period encompass a rise in the adoption of long-acting reversible contraceptives, a growing inclination towards non-hormonal contraceptive choices, an increased demand for female-controlled birth control methods, the wider availability of over-the-counter and self-administered products, and an intensified focus on contraceptive education for adolescents and young adults.
Get A Free Sample Report With In-Depth Market Insights:
Contraceptives Market Growth Factors: What’s Supporting Expansion?
The worldwide increase in population rates is projected to stimulate the growth of the contraceptive market in the upcoming years. Population denotes the overall number of individuals, species, or people residing within a particular geographic region, country, or the entire world. Contraceptives play a crucial role in reducing population by allowing couples and individuals to manage and plan their family size and the spacing of their children. As an illustration, in December 2024, according to the United States Census Bureau, a US-based federal agency, the U.S. population reached 340.1 million as of July 1, 2024, which indicated a 0.98% increase from 336.8 million in 2023, marking the highest annual growth rate recorded. Therefore, the global rise in population rates is significantly driving the contraceptive market.
Contraceptives Market Segment Outlook: Which Categories Are Growing Fastest?
The contraceptives market covered in this report is segmented –
1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices
2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years
3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels
Subsegments:
1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills
2) By Topical Contraceptives: Transdermal Patches, Gel Applications
3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables
4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms
5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings
6) By Condoms: Male Condoms, Female Condoms
7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges
8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants
9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs
Contraceptives Market Industry Trends: What’s Reshaping Demand?
Leading firms in the contraceptives sector are prioritizing new products, including Opill, progestin-only daily oral contraceptives, to more effectively address the demands of their current user base. Frequently referred to as the mini-pill, Opill progestin-only daily oral contraceptives are a contraceptive pill type containing solely progestin, which is a synthesized form of the hormone progesterone. An example of this is when, in July 2023, Perrigo Company plc, an Ireland-based manufacturer of over-the-counter pharmaceuticals, declared that the U. S. Food and Drug Administration (FDA) had approved Opill progestin-only daily oral contraceptives. In the United States, Opill marks the inaugural birth control pill accessible without a prescription. This product has the potential to considerably enhance women’s access to contraceptives and stands as a true reflection of Perrigo’s ongoing commitment to providing impactful solutions that positively affect individuals’ lives.
Contraceptives Market Leading Companies And Competitive Benchmarking
Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.
View The Full Contraceptives Market Report:
Contraceptives Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model